Benzinga Share: Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Roche (OTC: RHHBY) has submitted a line extension application to the European Medicines Agency for a subcutaneous (SC) …
Article by stock medicines – Google Blog Search. Read entire story here.
